Literature DB >> 11390475

Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.

G Katz1, G Markel, S Mizrahi, T I Arnon, O Mandelboim.   

Abstract

NK cells are cytotoxic to virus-infected and tumor cells that have lost surface expression of class I MHC proteins. Target cell expression of class I MHC proteins inhibits NK cytotoxicity through binding to inhibitory NK receptors. In contrast, a similar family of activating NK receptors, characterized by the presence of a charged residue in their transmembrane portion and a truncated cytoplasmic tail, augment lysis by NK cells when ligated by an appropriate class I MHC protein. However, the class I MHC specificity of many of these activating NK receptors is still unknown. Here, we show enhanced lysis of HLA-Cw4 but not HLA-Cw6-expressing cells, by a subset of NK clones. This subset may express killer cell Ig-like receptor two-domain short tail number 4 (KIR2DS4), as suggested by staining with various mAb. It is still possible, however, that these clones may express receptors other than KIR2DS4 that might recognize HLA-Cw4. Binding of KIR2DS4-Ig fusion protein to cells expressing HLA-Cw4 but not to those expressing HLA-Cw6 was also observed. The binding of KIR2DS4-Ig to HLA-Cw4 is weaker than that of killer cell Ig-like receptor two-domain long tail number 1 (KIR2DL1)-Ig fusion protein; however, such weak recognition is capable of inhibiting lysis by an NK transfectant expressing a chimeric molecule of KIR2DS4 fused to the transmembrane and cytoplasmic portion of KIR2DL1. Residue alpha14 is shown to be important in the KIR2DS4 binding to HLA-Cw4. Implications of the role of the activating NK receptors in immunosurveillance are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390475     DOI: 10.4049/jimmunol.166.12.7260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions.

Authors:  Gal Markel; Dana Wolf; Jacob Hanna; Roi Gazit; Debra Goldman-Wohl; Yuval Lavy; Simcha Yagel; Ofer Mandelboim
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.

Authors:  Tiernan J Mulrooney; Phillip E Posch; Carolyn Katovich Hurley
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

4.  Characterization and polymorphic analysis of 4.5 kb genomic full-length HLA-C in the Chinese Han population.

Authors:  Y Xu; Z Deng; C O'hUigin; D Wang; S Gao; J Zeng; B Yang; S Jin; H Zou
Journal:  Tissue Antigens       Date:  2011-06-09

5.  Conservation of sequence motifs suggests that the nonclassical MHC class I lineages CD1/PROCR and UT were established before the emergence of tetrapod species.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi; Unni Grimholt
Journal:  Immunogenetics       Date:  2017-12-21       Impact factor: 2.846

6.  Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

Authors:  A Conesa; M Fernández-Mestre; D Padrón; F Toro; N Silva; P Tassinari; I Blanca; M P Martin; M Carrington; Z Layrisse
Journal:  Tissue Antigens       Date:  2010-02-24

7.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Authors:  Frank Cichocki; Rebecca J Hanson; Todd Lenvik; Michelle Pitt; Valarie McCullar; Hongchuan Li; Stephen K Anderson; Jeffrey S Miller
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

Review 8.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 9.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

10.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.

Authors:  Thorsten Graef; Achim K Moesta; Paul J Norman; Laurent Abi-Rached; Luca Vago; Anastazia M Older Aguilar; Michael Gleimer; John A Hammond; Lisbeth A Guethlein; David A Bushnell; Philip J Robinson; Peter Parham
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.